Anbio Biotechnology (NASDAQ:NNNN) Hits New 52-Week Low – Here’s Why

Anbio Biotechnology (NASDAQ:NNNN) shares hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $6.06 and last traded at $6.11, with a volume of 307649 shares trading hands. The stock had previously closed at $6.34.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings cut shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, July 29th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, Anbio Biotechnology currently has a consensus rating of “Sell”.

Anbio Biotechnology Stock Performance

The company’s 50 day moving average price is $8.63 and its two-hundred day moving average price is $18.30.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.